+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Molecular Characterization of Carbapenem Resistant Isolates of Acinetobacter baumannii in An Intensive Care Unit of A Tertiary Care Centre at Central India



Molecular Characterization of Carbapenem Resistant Isolates of Acinetobacter baumannii in An Intensive Care Unit of A Tertiary Care Centre at Central India



Journal of Clinical and Diagnostic Research 8(5): Dc38-Dc40



To detect genes encoding carbapenem resistance in Acinetobacter baumannii in an intensive care unit. A. baumannii isolates were recovered from various clinical specimens of hospitalized patients admitted to the Medical and Surgical intensive care units of a tertiary care centre in Pune. Bacterial identification was performed by routine conventional microbial culture and biochemical tests using standard recommended techniques. Antibiotic sensitivity test was performed by standard Kirby Bauer disc diffusion technique. PCR amplification and automated sequencing was carried out. A total of 155 /368 (42.11%) isolates A. baumannii were found to have reduced susceptibility to imipenem (diameter of zones of inhibition ≤13mm) by disc diffusion method. Among these 155 isolates tested 130 (83.87%) isolates showed MIC values for imipenem and meropenem ranging from16-64 mg/L as per CLSI breakpoints. Among these 155 isolates, Carbapenemase production was confirmed by Modified Hodge test for 93 (60%) isolates. Out of 155 isolates, DDST was positive for 89 (57.41%), CDST was positive for 73(47.09%) and MBL (IP/IPI) E-test was positive for 105 (67.74%). blaOXA-51 gene was detected in 47/105 (44.76%), blaOXA-23 gene in 55/105 (52.38%) and blaOXA-58 like gene in 15/105 (14.28%). MBL production along with co- production of OXA enzymes are considered to be the important reason for resistance to imipenem in Acinetobacter in our health care settings. Hence, early detection of these drug resistant genes by molecular methods is essential in limiting the spread of infection due to these organisms.

(PDF emailed within 0-6 h: $19.90)

Accession: 054430845

Download citation: RISBibTeXText

PMID: 24995182

DOI: 10.7860/JCDR/2014/7749.4398


Related references

Molecular Characterization of Invasive Carbapenem-Resistant Acinetobacter baumannii from a Tertiary Care Hospital in South India. Infectious Diseases and Therapy 5(3): 379-387, 2016

Occurrence of bla genes encoding carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii from Intensive Care Unit in a tertiary care hospital. Journal of Laboratory Physicians 10(2): 208-213, 2018

Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii in the Intensive Care Unit of Uruguay's University Hospital Identifies the First rmtC Gene in the Species. Microbial Drug Resistance, 2018

Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia. New Microbiologica 37(1): 65-73, 2014

Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey. Journal of Hospital Infection 92(1): 67-72, 2016

Molecular characterization of plasmid-mediated blactx-M15 extended spectrum β lactamase (esbls) in Acinetobacter spp. Isolates from intensive care unit patients, at a tertiary care hospital, South India. Indian Journal of Medical Microbiology 33(4): 601-602, 2016

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii clinical isolates from the respiratory department of a tertiary care hospital in Henan, China. Journal of Global Antimicrobial Resistance 3(4): 309-310, 2016

Molecular characterization and resistance profile of nosocomial Acinetobacter baumannii intensive care unit of tertiary care hospital in Bangladesh. Bangladesh Medical Research Council Bulletin 41(2): 101-107, 2018

In vitro antimicrobial synergy studies of carbapenem-resistant Acinetobacter baumannii isolated from intensive care units of a tertiary care hospital in Egypt. Journal of Infection and Public Health 8(6): 593-602, 2016

Carbapenem-resistant Acinetobacter baumannii contamination in an intensive care unit. Revista Da Sociedade Brasileira de Medicina Tropical 50(2): 167-172, 2017

Molecular and epidemiological characterisation of clinical isolates of carbapenem-resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan. Journal of Hospital Infection 78(2): 143-148, 2011

First report of molecular characterization of carbapenem-resistant Acinetobacter baumannii in different intensive care units in University Hospital Split, Croatia. Journal of ChemoTherapy 19(4): 462-464, 2007

Endemic carbapenem-resistant Acinetobacter baumannii in a Brazilian intensive care unit. Journal of Hospital Infection 72(4): 365-368, 2009

Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection 38(3): 173-180, 2010

Management and control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. Medecine et Maladies Infectieuses 44(5): 229-231, 2015